Kyle H Molberg
Overview
Explore the profile of Kyle H Molberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lennerz J, Pantanowitz L, Amin M, Eltoum I, Hameed M, Kalof A, et al.
Nat Med
. 2022 Oct;
28(12):2453-2455.
PMID: 36266514
No abstract available.
2.
Chen H, Lucas E, Strickland A, Carrick K, Gwin K, Castrillon D, et al.
Am J Surg Pathol
. 2020 Sep;
44(10):1429-1439.
PMID: 32931681
Background: Conservative management with progestin is a treatment option for atypical hyperplasia (AH). However, pathologic diagnosis of residual/recurrent lesions is often problematic because of the profound morphologic changes induced by...
3.
Dang D, Raj G, Sarode V, Molberg K, Vadlamudi R, Peng Y
Hum Pathol
. 2015 Oct;
46(12):1829-35.
PMID: 26428280
PELP1 is a novel coregulator of nuclear hormone receptors and is implicated in playing a role in driving breast cancer and enhancing metastatic potential. The PELP1 protein expression and potential...
4.
Sutton L, Cao D, Sarode V, Molberg K, Torgbe K, Haley B, et al.
Am J Clin Pathol
. 2012 Sep;
138(4):511-6.
PMID: 23010705
To characterize prognostic values of androgen receptor (AR) in triple-negative (TN) breast cancers, we investigated AR expression status and levels, explored an association of AR expression with metastatic disease, and...
5.
Han J, Molberg K, Sarode V
Breast J
. 2011 May;
17(3):223-9.
PMID: 21545433
The diagnosis of ductal carcinoma in situ (DCIS) using core biopsy does not ensure the absence of invasion on final excision. We performed a retrospective analysis of 255 patients with...
6.
Karpowicz M, Shalmon B, Molberg K, El-Naggar A
Hum Pathol
. 2011 Mar;
42(9):1355-8.
PMID: 21411120
A rare example of melanoma arising in carcinoma ex pleomorphic adenoma is presented. The diagnosis, differential diagnosis, and putative histogenesis of the melanoma component are discussed.
7.
Han J, Cao D, Molberg K, Sarode V, Rao R, Sutton L, et al.
Am J Clin Pathol
. 2011 Jan;
135(2):230-7.
PMID: 21228363
Triple-negative (TN) breast carcinoma is associated with a higher recurrence rate and shorter survival and lacks the benefit of specific therapy. TN tumors usually express high levels of Ki-67 and...
8.
Sutton L, Han J, Molberg K, Sarode V, Cao D, Rakheja D, et al.
Am J Clin Pathol
. 2010 Oct;
134(5):782-7.
PMID: 20959661
Triple-negative (TN) breast carcinoma, characterized by estrogen receptor, progesterone receptor, and HER2 negativity, is a group of aggressive tumors that can be further classified into 2 subtypes: basal-like, defined as...
9.
Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D, et al.
Am J Surg Pathol
. 2009 Jul;
33(10):1529-39.
PMID: 19574883
Extragonadal yolk sac tumors (YSTs; primary and metastatic) are rare but are malignant germ cell tumors. Pathologic diagnosis of extragonadal YSTs can be challenging without immunohistochemical markers but markers used...
10.
Peng Y, Wang H, Molberg K
Arch Otolaryngol Head Neck Surg
. 2009 Jun;
135(6):606-10.
PMID: 19528411
No abstract available.